Índice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis

Vista sencilla de ítem
dc.contributor.advisorRomero Infante , Ximena Carolina
dc.contributor.advisorDe la Hoz Valle , José
dc.contributor.advisorRomero Infante, Ximena Carolina
dc.contributor.advisorSarmiento, Diana Piedad
dc.contributor.advisorSánchez, Sandra Milena
dc.contributor.authorEchavez Cervantes, Israel David
dc.date.accessioned2024-08-08T18:51:06Z
dc.date.available2024-08-08T18:51:06Z
dc.date.issued2024-01
dc.description.abstractDeterminar el rendimiento diagnóstico del índice proteína/creatinina para identificar desenlaces materno-perinatales adversos en pacientes con preeclampsia, de acuerdo con una revisión sistemática de la literatura y metaanálisis. Se utilizaron las bases de datos PubMed, ClinicalKey, Cochrane y Web of Science entre el año 2005 y el 2022 utilizando palabras clave. Se incluyeron artículos de tipo transversal, de cohorte, casos y controles, y ensayos clínicos en idioma inglés. Métodos de evaluación y síntesis el estudio: se siguieron las recomendaciones Prisma y se registró en PROSPRO CRD42022373064 Los resultados se dividieron en resultados adversos tanto materno como fetales. Para la evaluación de calidad se usó la herramienta Quadas-2. El cálculo de sensibilidad y especificidad se realizó de forma agrupada por medio del método de efectos aleatorios de Mantel-Haenszel. Todos los resultados se presentaron con intervalos de confianza. También se calculó el área bajo la Curva Operador Receptor. La heterogeneidad se evaluó mediante la inconsistencia (I2) y el estadístico Q de Cochran.
dc.description.abstractenglishTo determine the diagnostic performance of the protein/creatinine ratio to identify adverse maternal-perinatal outcomes in patients with preeclampsia, according to a systematic review of the literature and meta-analysis. The PubMed, ClinicalKey, Cochrane and Web of Science databases were used between 2005 and 2022 using keywords. Cross-sectional, cohort, case-control, and clinical trials in English were included. Methods of evaluation and synthesis of the study: Prisma recommendations were followed and registered in PROSPRO CRD42022373064. The results were divided into adverse maternal and fetal outcomes. The Quadas-2 tool was used for quality assessment. The calculation of sensitivity and specificity was performed in a pooled manner using the Mantel-Haenszel random effects method. All results were presented with confidence intervals. The area under the Receiver Operator Curve was also calculated. Heterogeneity was assessed using inconsistency (I2) and Cochran's Q statistic.
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Medicina Materno-Fetalspa
dc.format.mimetypeapplication/pdf
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/12852
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.grantorUniversidad El Bosquespa
dc.publisher.programEspecialización en Medicina Materno-Fetalspa
dc.relation.referencesPoon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33.
dc.relation.referencesWiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3.
dc.relation.referencesShreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9.
dc.relation.referencesShahbazian N, Hosseini-Asl F. A Comparison of Spot Urine Protein-Creatinine Ratio With 24-hour Urine Protein Excretion in Women With Preeclampsia. Kidney Diseases. 2008;2(3):127–31.
dc.relation.referencesBhavana B, Usha M, Sunita G, Navjot B. Comparison of protein / creatinine ratio in single voided urine sample with 24 hours urine protein for estimation of proteinuria in pregnancy induced hypertension P : C. 2009;59(5):424–6.
dc.relation.referencesKayatas S, Erdogdu E, Cakar E, Yilmazer V, Arinkan SA, Dayicioglu VE. Comparison of 24-hour urinary protein and protein-to-creatinine ratio in women with preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2013;170(2):368–71.
dc.relation.referencesShahbazian N, Hosseini-Asl F. A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. Iran J Kidney Dis. 2008;2(3):127–31.
dc.relation.referencesCassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23.
dc.relation.referencesXiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9.
dc.relation.referencesYing W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc. 2018;7(17):1–9.
dc.relation.referencesJung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol [Internet]. 2022;226(2):S844–66. Available from: https://doi.org/10.1016/j.ajog.2021.11.1356
dc.relation.referencesPérez De Villa A, Álvarez A, Clavero EP, María Hernández Placía R. Preeclampsia: Characteristics and Consequences. Revista Finlay [Internet]. 2015;5(2):118–29. Available from: http://www.revfinlay.sld.cu/index.php/finlay/article/view/354
dc.relation.referencesGhossein-Doha C, Peeters L, Van Heijster S, Van Kuijk S, Spaan J, Delhaas T, et al. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension. 2013;62(2):382–90.
dc.relation.referencesErez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol [Internet]. 2022;226(2):S786–803. Available from: http://dx.doi.org/10.1016/j.ajog.2021.12.001
dc.relation.referencesBolarte N, Loli S, Torres Y, Pezo-Pezo Armando, Gonzales M, Quispe A. Desenlaces neonatales adversos en gestantes con preeclampsia severa y sus factores asociados. Revista Cuerpo Medico [Internet]. 2019;12(2):113–8. Available from: www.ucalgary.ca/fenton/2013chart
dc.relation.referencesKale PL, Fonseca SC. Intrauterine growth restriction, prematurity, and low birth weight: risk phenotypes of neonatal death, Rio de Janeiro State, Brazil. Cad Saude Publica. 2023;39(6).
dc.relation.referencesSánchez-Cobo D, Copado-Mendoza DY, Valdespino-Vázquez MY, Rodríguez-Sibaja MJ, Acevedo-Gallegos S. Morphological changes in placentas of patients with preeclampsia or intrauterine growth restriction and interpretation of perinatal outcomes. Ginecol Obstet Mex. 2021 Nov 1;89(11):875–83.
dc.relation.referencesAlfonso L, Tascón M, Isabel D, Benítez C, Osorio MÁ, Isabel L, et al. Trabajos Originales Epidemiología de la prematuridad y sus determinantes , en una población de mujeres adolescentes y adultas de Colombia. 2016;81(5):372–80.
dc.relation.referencesRomero Infante XC, Uriel M, Porras Ramírez A, Rincón Franco S. Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population. Journal of Obstetrics and Gynaecology Research. 2021;47(2):765–73.
dc.relation.referencesDe Haas S, Ghossein-Doha C, Geerts L, van Kuijk SMJ, van Drongelen J, Spaanderman MEA. Cardiac remodeling in normotensive pregnancy and in pregnancy complicated by hypertension: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology. 2017;50(6):683–96.
dc.relation.referencesLei T, Qiu T, Liao W, Li K, Lai X, Huang H, et al. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reproductive Biology and Endocrinology. 2021 Dec 1;19(1).
dc.relation.referencesShreya G, Pranathi L, Kvitha V. Comparison of spot urine protein- creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. International Journal of Integrative Medical Sciences. 2015;2((1)):55–9.
dc.relation.referencesP S, Bharathi D, V Kate N. The diagnostic accuracy of spot urine protein-creatinine ratio (UPCR) in quantification of proteinuria in women with preeclampsia. Indian Journal of Obstetrics and Gynecology Research. 2021 Mar 28;6(2):185–91.
dc.relation.referencesMcInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement. JAMA - Journal of the American Medical Association. 2018;319(4):388–96.
dc.relation.referencesTricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73.
dc.relation.referencesUrrutia G, Bonfill X. Declaración PRISMA : una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 2011;135(11):507–11.
dc.relation.referencesCheung HC, Leung KY, Choi CH. Diagnostic accuracy of spot urine protein-to-creatinine ratio for proteinuria and its association with adverse pregnancy outcomes in Chinese pregnant patients with pre-eclampsia. Hong Kong Medical Journal. 2016 Jun 1;22(3):249–55.
dc.relation.referencesPayne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, et al. PIERS Proteinuria: Relationship With Adverse Maternal and Perinatal Outcome. Journal of Obstetrics and Gynaecology Canada. 2011;33(6):588–97.
dc.relation.referencesNischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women [Internet]. Available from: www.jnsbm.org
dc.relation.referencesWaugh J, Hooper R, Lamb E, Robson S, Shennan A, Milne F, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: A diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess (Rockv). 2017 Oct 1;21(61):1–90.
dc.relation.referencesChadha A, Tayade S. Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria. Cureus. 2022;14(3).
dc.relation.referencesChan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: How much matters? BJOG. 2005 Mar;112(3):280–5.
dc.relation.referencesXiao J, Fan W, Zhu Q, Shi Z. Diagnosis of proteinuria using a random urine protein‐creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage. The Journal of Clinical Hypertension. 2022;(February):652–9.
dc.relation.referencesChung WH, To WWK. Outcome of pregnancy with new onset proteinuria and progression to pre-eclampsia: A retrospective analysis. Pregnancy Hypertens. 2018 Apr 1;12:174–7.
dc.relation.referencesKuper SG, Tita AT, Youngstrom ML, Allen SE, Tang Y, Biggio JR, et al. Baseline renal function tests and adverse outcomes in pregnant patients with chronic hypertension. Obstetrics and Gynecology. 2016 Jul 1;128(1):93–103.
dc.relation.referencesMorikawa M, Mayama M, Saito Y, Nakagawa-Akabane K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020 Jan 1;19:119–26.
dc.relation.referencesKumari A, Chakrawarty A, Singh A, Singh R. Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country. J Pregnancy. 2014;2014.
dc.relation.referencesCáceres MAM, Pedraza LCM, Mojica CHB, Martínez LAD. Maternal and fetal outcomes of pregnancies with hypertensive disorders: A cross-sectional study. Rev Chil Obstet Ginecol. 2020;85(1):14–23.
dc.relation.referencesWiwanitkit V. Periodic urinary protein creatinine ratio for predicting significant proteinuria in preeclampsia in different alternatives: Time effectiveness analysis. Arch Gynecol Obstet. 2010;281(3):571–3.
dc.relation.referencesPoon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology and Obstetrics. 2019;145(S1):1–33.
dc.relation.referencesCassiano ADN, Vitorino ABF, Oliveira SIM de, Silva MDLC da, Souza NML de, Souza NL de. Desfechos perinatais em gestantes com síndromes hipertensivas: revisão integrativa. Revista de Enfermagem da UFSM. 2020;10:e23.
dc.relation.referencesBravo-Grau S, Cruz JP. Estudios de exactitud diagnóstica: Herramientas para su Interpretación. Revista Chilena de Radiología. 2015;21(4):158–64.
dc.relation.referencesCade TJ, Gilbert SA, Polyakov A, Hotchin A. The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2012 Apr;52(2):179–82.
dc.relation.referencesMartins-Costa SH, Vettorazzi J, Valério E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: Maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331–7.
dc.rightsAtribución-NoComercial-CompartirIgual 4.0 Internacionalen
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.localAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectDesenlace del embarazo
dc.subjectRatio proteína/creatinina
dc.subjectEmbarazo
dc.subject.keywordsPregnancy outcome
dc.subject.keywordsPotein/creatinine ratio
dc.subject.keywordsPregnancy
dc.subject.nlmWQ 200
dc.titleÍndice proteína/creatinina y desenlaces materno-perinatales adversos en preeclampsia: revisión sistemática y metaanálisis
dc.title.translatedCreatinine protein index and adverse maternal-perinatal outcomes in pre-eclampsia: systematic review and meta-analysis
dc.type.coarhttps://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttps://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driverinfo:eu-repo/semantics/bachelorThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesis/Trabajo de grado - Monografía - Especializaciónspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Trabajo de grado.pdf
Tamaño:
1.05 MB
Formato:
Adobe Portable Document Format
Descargar
Bloque de licencias
Mostrando 1 - 3 de 3
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.95 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
No hay miniatura disponible
Nombre:
Carta autorización.pdf
Tamaño:
124.33 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
No hay miniatura disponible
Nombre:
Acta de grado.pdf
Tamaño:
180.46 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar

Colecciones

Especialización en Medicina Materno-Fetal